April 2026
Cuffless blood pressure monitoring devices represent one of the most promising yet controversial innovations in contemporary hypertension care. By enabling continuous, unobtrusive BP assessment, they hold the potential to transform diagnosis and long-term management. However, as highlighted by Parati et al., current technologies remain limited by insufficient accuracy, lack of standardized validation, and reliance on indirect physiological surrogates. Despite growing commercial availability, these devices cannot yet be recommended for clinical decision-making, in line with international guidelines. The challenge ahead is clear: rigorous validation and demonstration of clinical benefit must precede widespread adoption, ensuring that technological progress translates into meaningful improvements in cardiovascular outcomes.